WV5-18398-61327
3 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 021 / MA
- Registered
- 2021-04-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-24
Dose 1 — Pfizer-BioNTech
-
2021-04-27
Registered in v-safe
- 2021-05-11
- 2021-05-15
-
2021-05-18
Dose 2 — Pfizer-BioNTech
- 2021-05-22
- 2021-05-24
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-08-17
- 2021-11-17
-
2021-11-19
Dose 3 — Moderna
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Itching · Fatigue or tirednessAdult check-in
- 2021-11-21
- 2021-11-22
- 2021-12-05
- 2021-12-12
- 2022-01-02
-
2022-05-26
Survey response — 6 months, dose 3MedDRA: Malaise — Feeling: Good · Be unable to do your normal daily activitiesFree text: COVID symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-11-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-24 | Pfizer-BioNTech | |
| 2 | 2021-05-18 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Moderna | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: COVID symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malaise | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release